Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Basisinformatie over zeldzame hersentumoren bij volwassenen
jul 2022 | Neuro-oncologie